Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial 2007 study identifying heart risks in GlaxoSmithKline's Avandia diabetes drug. He talks to CNBC's Mike Huckman.
AOL
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT